{
  "DOI": "10.1007/s00439-021-02369-x",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-021-02369-x",
  "alternative-id": [
    "2369"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "5 July 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "9 September 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "1 October 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "GPP is Full Member and National Representative at the European medicines Agency, Committee for Human Medicinal Products (CHMP)—Pharmacogenomics Working Party, Amsterdam, the Netherlands."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-8592-7790",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Tsermpini",
      "given": "Evangelia Eirini",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-4673-6692",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Al-Mahayri",
      "given": "Zeina N.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-1306-6618",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Ali",
      "given": "Bassam R.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-0519-7776",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Patrinos",
      "given": "George P.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        10,
        1
      ]
    ],
    "date-time": "2021-10-01T19:22:05Z",
    "timestamp": 1633116125000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        6,
        9
      ]
    ],
    "date-time": "2022-06-09T02:08:36Z",
    "timestamp": 1654740516000
  },
  "funder": [
    {
      "DOI": "10.13039/501100000780",
      "award": [
        "668353"
      ],
      "doi-asserted-by": "publisher",
      "name": "european commission"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        8
      ]
    ],
    "date-time": "2024-04-08T19:52:15Z",
    "timestamp": 1712605935766
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "6",
  "issued": {
    "date-parts": [
      [
        2021,
        10,
        1
      ]
    ]
  },
  "journal-issue": {
    "issue": "6",
    "published-print": {
      "date-parts": [
        [
          2022,
          6
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            10,
            1
          ]
        ],
        "date-time": "2021-10-01T00:00:00Z",
        "timestamp": 1633046400000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            10,
            1
          ]
        ],
        "date-time": "2021-10-01T00:00:00Z",
        "timestamp": 1633046400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s00439-021-02369-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s00439-021-02369-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s00439-021-02369-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1137-1157",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2021,
        10,
        1
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        10,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1186/s13073-020-00821-7",
      "author": "AN Abou Tayoun",
      "doi-asserted-by": "publisher",
      "first-page": "116",
      "journal-title": "Genome Med",
      "key": "2369_CR1",
      "unstructured": "Abou Tayoun AN, Rehm HL (2020) Genetic variation in the Middle East-an opportunity to advance the human genetics field. Genome Med 12:116. https://doi.org/10.1186/s13073-020-00821-7",
      "volume": "12",
      "year": "2020"
    },
    {
      "DOI": "10.2217/pgs-2019-0047",
      "author": "KT Bain",
      "doi-asserted-by": "publisher",
      "first-page": "709",
      "journal-title": "Pharmacogenomics",
      "key": "2369_CR2",
      "unstructured": "Bain KT, Matos A, Knowlton CH, McGain D (2019) Genetic variants and interactions from a pharmacist-led pharmacogenomics service for PACE. Pharmacogenomics 20:709–718. https://doi.org/10.2217/pgs-2019-0047",
      "volume": "20",
      "year": "2019"
    },
    {
      "DOI": "10.2217/pgs-2019-0197",
      "author": "KT Bain",
      "doi-asserted-by": "publisher",
      "first-page": "651",
      "journal-title": "Pharmacogenomics",
      "key": "2369_CR3",
      "unstructured": "Bain KT, Knowlton CH, Matos A (2020) Cost avoidance related to a pharmacist-led pharmacogenomics service for the Program of All-inclusive Care for the Elderly. Pharmacogenomics 21:651–661. https://doi.org/10.2217/pgs-2019-0197",
      "volume": "21",
      "year": "2020"
    },
    {
      "DOI": "10.1016/BS.APHA.2018.04.003",
      "author": "PCD Bank",
      "doi-asserted-by": "publisher",
      "first-page": "219",
      "journal-title": "Adv Pharmacol",
      "key": "2369_CR4",
      "unstructured": "Bank PCD, Swen JJ, Guchelaar H-J (2018) Implementation of pharmacogenomics in everyday clinical settings. Adv Pharmacol 83:219–246. https://doi.org/10.1016/BS.APHA.2018.04.003",
      "volume": "83",
      "year": "2018"
    },
    {
      "DOI": "10.1038/S41431-019-0454-X",
      "author": "PCD Bank",
      "doi-asserted-by": "publisher",
      "first-page": "1532",
      "journal-title": "Eur J Hum Genet",
      "key": "2369_CR5",
      "unstructured": "Bank PCD, Swen JJ, Schaap RD et al (2019) A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care. Eur J Hum Genet 27:1532. https://doi.org/10.1038/S41431-019-0454-X",
      "volume": "27",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.mayocp.2013.10.021",
      "author": "SJ Bielinski",
      "doi-asserted-by": "publisher",
      "first-page": "25",
      "journal-title": "Mayo Clin Proc",
      "key": "2369_CR6",
      "unstructured": "Bielinski SJ, Olson JE, Pathak J et al (2014) Preemptive genotyping for personalized medicine: design of the Right Drug, Right Dose, Right Time—using genomic data to individualize treatment protocol. Mayo Clin Proc 89:25–33. https://doi.org/10.1016/j.mayocp.2013.10.021",
      "volume": "89",
      "year": "2014"
    },
    {
      "DOI": "10.1093/ije/dyz123",
      "author": "SJ Bielinski",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "journal-title": "Int J Epidemiol",
      "key": "2369_CR7",
      "unstructured": "Bielinski SJ, St Sauver JL, Olson JE et al (2020) Cohort profile: the right drug, right dose, right time: using genomic data to individualize treatment protocol (RIGHT protocol). Int J Epidemiol 49:23–24k. https://doi.org/10.1093/ije/dyz123",
      "volume": "49",
      "year": "2020"
    },
    {
      "DOI": "10.3111/13696998.2015.1110160",
      "author": "D Brixner",
      "doi-asserted-by": "publisher",
      "first-page": "213",
      "journal-title": "J Med Econ",
      "key": "2369_CR8",
      "unstructured": "Brixner D, Biltaji E, Bress A et al (2016) The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy. J Med Econ 19:213–228. https://doi.org/10.3111/13696998.2015.1110160",
      "volume": "19",
      "year": "2016"
    },
    {
      "DOI": "10.1002/cpt.350",
      "author": "WS Bush",
      "doi-asserted-by": "publisher",
      "first-page": "160",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR9",
      "unstructured": "Bush WS, Crosslin DR, Owusu-Obeng A et al (2016) Genetic variation among 82 pharmacogenes: the PGRNseq data from the eMERGE network. Clin Pharmacol Ther 100:160–169. https://doi.org/10.1002/cpt.350",
      "volume": "100",
      "year": "2016"
    },
    {
      "DOI": "10.1177/2050312115624333",
      "author": "JS Carpenter",
      "doi-asserted-by": "publisher",
      "journal-title": "SAGE Open Med",
      "key": "2369_CR10",
      "unstructured": "Carpenter JS, Rosenman MB, Knisely MR et al (2016) Pharmacogenomically actionable medications in a safety net health care system. SAGE Open Med. https://doi.org/10.1177/2050312115624333",
      "year": "2016"
    },
    {
      "DOI": "10.2217/pgs-2017-0028",
      "author": "LH Cavallari",
      "doi-asserted-by": "publisher",
      "first-page": "421",
      "journal-title": "Pharmacogenomics",
      "key": "2369_CR11",
      "unstructured": "Cavallari LH, Weitzel KW, Elsey AR et al (2017) Institutional profile: University of Florida Health Personalized Medicine Program. Pharmacogenomics 18:421–426. https://doi.org/10.2217/pgs-2017-0028",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.2217/pgs-2016-0164",
      "author": "CYW Chan",
      "doi-asserted-by": "publisher",
      "first-page": "531",
      "journal-title": "Pharmacogenomics",
      "key": "2369_CR12",
      "unstructured": "Chan CYW, Chua BY, Subramaniam M et al (2017) Clinicians’ perceptions of pharmacogenomics use in psychiatry. Pharmacogenomics 18:531–538. https://doi.org/10.2217/pgs-2016-0164",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1159/000502916",
      "author": "S Chumnumwat",
      "doi-asserted-by": "publisher",
      "first-page": "132",
      "journal-title": "Public Health Genomics",
      "key": "2369_CR13",
      "unstructured": "Chumnumwat S, Lu ZH, Sukasem C et al (2019) Southeast Asian Pharmacogenomics Research Network (SEAPharm): current status and perspectives. Public Health Genomics 22:132–139. https://doi.org/10.1159/000502916",
      "volume": "22",
      "year": "2019"
    },
    {
      "DOI": "10.9778/cmajo.20150070",
      "author": "M Dawes",
      "doi-asserted-by": "publisher",
      "first-page": "E528",
      "journal-title": "C Open",
      "key": "2369_CR14",
      "unstructured": "Dawes M, Aloise MN, Ang JS et al (2016) Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study. C Open 4:E528–E534. https://doi.org/10.9778/cmajo.20150070",
      "volume": "4",
      "year": "2016"
    },
    {
      "DOI": "10.1038/537S60a",
      "author": "L Drew",
      "doi-asserted-by": "publisher",
      "first-page": "S60",
      "journal-title": "Nature",
      "key": "2369_CR15",
      "unstructured": "Drew L (2016) Pharmacogenetics: the right drug for you. Nature 537:S60–S62. https://doi.org/10.1038/537S60a",
      "volume": "537",
      "year": "2016"
    },
    {
      "DOI": "10.2147/PGPM.S241599",
      "author": "BQ Duong",
      "doi-asserted-by": "publisher",
      "first-page": "217",
      "journal-title": "Pharmgenomics Pers Med",
      "key": "2369_CR16",
      "unstructured": "Duong BQ, Arwood MJ, Hicks JK et al (2020) Development of customizable implementation guides to support clinical adoption of pharmacogenomics: experiences of the implementing GeNomics In pracTicE (IGNITE) Network. Pharmgenomics Pers Med 13:217–226. https://doi.org/10.2147/PGPM.S241599",
      "volume": "13",
      "year": "2020"
    },
    {
      "DOI": "10.1002/cpt.347",
      "author": "MT Eadon",
      "doi-asserted-by": "publisher",
      "first-page": "63",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR17",
      "unstructured": "Eadon MT, Desta Z, Levy KD et al (2016) Implementation of a pharmacogenomics consult service to support the INGENIOUS trial. Clin Pharmacol Ther 100:63–66. https://doi.org/10.1002/cpt.347",
      "volume": "100",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s00439-021-02260-9",
      "author": "S El Shamieh",
      "doi-asserted-by": "publisher",
      "journal-title": "Hum Genet",
      "key": "2369_CR18",
      "unstructured": "El Shamieh S, Zgheib NK (2021) Pharmacogenetics in developing countries and low resource environments. Hum Genet. https://doi.org/10.1007/s00439-021-02260-9",
      "year": "2021"
    },
    {
      "DOI": "10.1371/journal.pone.0170905",
      "author": "LS Elliott",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS One",
      "key": "2369_CR19",
      "unstructured": "Elliott LS, Henderson JC, Neradilek MB et al (2017) Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: a prospective pilot randomized controlled trial. PLoS One 12:e0170905. https://doi.org/10.1371/journal.pone.0170905",
      "volume": "12",
      "year": "2017"
    },
    {
      "DOI": "10.2147/PGPM.S117014",
      "author": "J Finkelstein",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "journal-title": "Pharmgenomics Pers Med",
      "key": "2369_CR20",
      "unstructured": "Finkelstein J, Friedman C, Hripcsak G, Cabrera M (2016) Pharmacogenomics and Personalized Medicine Dovepress Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study. Pharmgenomics Pers Med 2016:9–107. https://doi.org/10.2147/PGPM.S117014",
      "volume": "2016",
      "year": "2016"
    },
    {
      "DOI": "10.2217/pgs-2018-0205",
      "author": "CR Fulton",
      "doi-asserted-by": "publisher",
      "first-page": "397",
      "journal-title": "Pharmacogenomics",
      "key": "2369_CR21",
      "unstructured": "Fulton CR, Zang Y, Desta Z et al (2019) Drug-gene and drug–drug interactions associated with tramadol and codeine therapy in the INGENIOUS trial. Pharmacogenomics 20:397–408. https://doi.org/10.2217/pgs-2018-0205",
      "volume": "20",
      "year": "2019"
    },
    {
      "DOI": "10.1038/SJ.CLPT.6100087",
      "author": "K Giacomini",
      "doi-asserted-by": "publisher",
      "first-page": "328",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR22",
      "unstructured": "Giacomini K, Brett C, Altman R et al (2007) The Pharmacogenetics Research Network: from SNP discovery to clinical drug response. Clin Pharmacol Ther 81:328. https://doi.org/10.1038/SJ.CLPT.6100087",
      "volume": "81",
      "year": "2007"
    },
    {
      "DOI": "10.2217/pgs-2016-0161",
      "author": "ML Gibson",
      "doi-asserted-by": "publisher",
      "first-page": "227",
      "journal-title": "Pharmacogenomics",
      "key": "2369_CR23",
      "unstructured": "Gibson ML, Hohmeier KC, Smith CT (2017) Pharmacogenomics testing in a community pharmacy: patient perceptions and willingness-to-pay. Pharmacogenomics 18:227–233. https://doi.org/10.2217/pgs-2016-0161",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.2217/pme-2019-0021",
      "author": "GS Ginsburg",
      "doi-asserted-by": "publisher",
      "first-page": "259",
      "journal-title": "Per Med",
      "key": "2369_CR24",
      "unstructured": "Ginsburg GS, Horowitz CR, Orlando LA (2019) What will it take to implement genomics in practice? Lessons from the IGNITE Network. Per Med 16:259–261. https://doi.org/10.2217/pme-2019-0021",
      "volume": "16",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41436-021-01118-9",
      "author": "GS Ginsburg",
      "doi-asserted-by": "publisher",
      "first-page": "1185",
      "journal-title": "Genet Med",
      "key": "2369_CR25",
      "unstructured": "Ginsburg GS, Cavallari LH, Chakraborty H et al (2021) Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network. Genet Med 23:1185–1191. https://doi.org/10.1038/s41436-021-01118-9",
      "volume": "23",
      "year": "2021"
    },
    {
      "DOI": "10.1038/gim.2013.72",
      "author": "O Gottesman",
      "doi-asserted-by": "publisher",
      "first-page": "761",
      "journal-title": "Genet Med",
      "key": "2369_CR26",
      "unstructured": "Gottesman O, Kuivaniemi H, Tromp G et al (2013a) The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med 15:761–771. https://doi.org/10.1038/gim.2013.72",
      "volume": "15",
      "year": "2013"
    },
    {
      "DOI": "10.1038/clpt.2013.72",
      "author": "O Gottesman",
      "doi-asserted-by": "publisher",
      "first-page": "214",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR27",
      "unstructured": "Gottesman O, Scott SA, Ellis SB et al (2013b) The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics. Clin Pharmacol Ther 94:214–217. https://doi.org/10.1038/clpt.2013.72",
      "volume": "94",
      "year": "2013"
    },
    {
      "DOI": "10.2217/pgs.14.118",
      "author": "SB Haga",
      "doi-asserted-by": "publisher",
      "first-page": "1729",
      "journal-title": "Pharmacogenomics",
      "key": "2369_CR28",
      "unstructured": "Haga SB, Allen LaPointe NM, Moaddeb J et al (2014a) Pilot study: incorporation of pharmacogenetic testing in medication therapy management services. Pharmacogenomics 15:1729–1737. https://doi.org/10.2217/pgs.14.118",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.2217/pgs.14.109",
      "author": "SB Haga",
      "doi-asserted-by": "publisher",
      "first-page": "1677",
      "journal-title": "Pharmacogenomics",
      "key": "2369_CR29",
      "unstructured": "Haga SB, LaPointe NMA, Cho A et al (2014b) Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting. Pharmacogenomics 15:1677–1686. https://doi.org/10.2217/pgs.14.109",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.4103/2153-3539.165999",
      "author": "TM Herr",
      "doi-asserted-by": "publisher",
      "first-page": "50",
      "journal-title": "J Pathol Inform",
      "key": "2369_CR30",
      "unstructured": "Herr TM, Bielinski SJ, Bottinger E et al (2015) Practical considerations in genomic decision support: the eMERGE experience. J Pathol Inform 6:50. https://doi.org/10.4103/2153-3539.165999",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1002/phar.1786",
      "author": "JK Hicks",
      "doi-asserted-by": "publisher",
      "first-page": "940",
      "journal-title": "Pharmacother J Hum Pharmacol Drug Ther",
      "key": "2369_CR31",
      "unstructured": "Hicks JK, Stowe D, Willner MA et al (2016) Implementation of clinical pharmacogenomics within a large health system: from electronic health record decision support to consultation services. Pharmacother J Hum Pharmacol Drug Ther 36:940–948. https://doi.org/10.1002/phar.1786",
      "volume": "36",
      "year": "2016"
    },
    {
      "DOI": "10.2146/ajhp150273",
      "author": "BT Hocum",
      "doi-asserted-by": "publisher",
      "first-page": "61",
      "journal-title": "Am J Health Syst Pharm",
      "key": "2369_CR32",
      "unstructured": "Hocum BT, White JR, Heck JW et al (2016) Cytochrome P-450 gene and drug interaction analysis in patients referred for pharmacogenetic testing. Am J Health Syst Pharm 73:61–67. https://doi.org/10.2146/ajhp150273",
      "volume": "73",
      "year": "2016"
    },
    {
      "DOI": "10.1002/AJMG.C.31391",
      "author": "JM Hoffman",
      "doi-asserted-by": "publisher",
      "journal-title": "Am J Med Genet C Semin Med Genet",
      "key": "2369_CR33",
      "unstructured": "Hoffman JM, Haidar CE, Wilkinson MR et al (2014) PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics. Am J Med Genet C Semin Med Genet. https://doi.org/10.1002/AJMG.C.31391",
      "year": "2014"
    },
    {
      "DOI": "10.2217/pme-2018-0151",
      "author": "C Holden",
      "doi-asserted-by": "publisher",
      "first-page": "409",
      "journal-title": "Per Med",
      "key": "2369_CR34",
      "unstructured": "Holden C, Bignell L, Mukhopadhyay S, Jones C (2019) The public perception of the facilitators and barriers to implementing personalized medicine: a systematic review. Per Med 16:409–420. https://doi.org/10.2217/pme-2018-0151",
      "volume": "16",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.cct.2015.12.020",
      "author": "CR Horowitz",
      "doi-asserted-by": "publisher",
      "first-page": "101",
      "journal-title": "Contemp Clin Trials",
      "key": "2369_CR35",
      "unstructured": "Horowitz CR, Abul-Husn NS, Ellis S et al (2016) Determining the effects and challenges of incorporating genetic testing into primary care management of hypertensive patients with African ancestry. Contemp Clin Trials 47:101–108. https://doi.org/10.1016/j.cct.2015.12.020",
      "volume": "47",
      "year": "2016"
    },
    {
      "DOI": "10.1038/CLPT.2012.125",
      "author": "J Johnson",
      "doi-asserted-by": "publisher",
      "first-page": "437",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR36",
      "unstructured": "Johnson J, Burkley B, Langaee T et al (2012) Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array. Clin Pharmacol Ther 92:437. https://doi.org/10.1038/CLPT.2012.125",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.2217/pgs.13.59",
      "author": "JA Johnson",
      "doi-asserted-by": "publisher",
      "first-page": "723",
      "journal-title": "Pharmacogenomics",
      "key": "2369_CR37",
      "unstructured": "Johnson JA, Elsey AR, Clare-Salzler MJ et al (2013) Institutional Profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics. Pharmacogenomics 14:723–726. https://doi.org/10.2217/pgs.13.59",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1002/hup.2383",
      "author": "MB Lanktree",
      "doi-asserted-by": "publisher",
      "first-page": "287",
      "journal-title": "Hum Psychopharmacol Clin Exp",
      "key": "2369_CR38",
      "unstructured": "Lanktree MB, Zai G, VanderBeek LE et al (2014) Positive perception of pharmacogenetic testing for psychotropic medications. Hum Psychopharmacol Clin Exp 29:287–291. https://doi.org/10.1002/hup.2383",
      "volume": "29",
      "year": "2014"
    },
    {
      "DOI": "10.1093/ajhp/zxy072",
      "author": "E Leary",
      "doi-asserted-by": "publisher",
      "first-page": "387",
      "journal-title": "Am J Health Syst Pharm",
      "key": "2369_CR39",
      "unstructured": "Leary E, Brilliant M, Peissig P, Griesbach S (2019) Preliminary outcomes of preemptive warfarin pharmacogenetic testing at a large rural healthcare center. Am J Health Syst Pharm 76:387–397. https://doi.org/10.1093/ajhp/zxy072",
      "volume": "76",
      "year": "2019"
    },
    {
      "DOI": "10.2217/pgs-2017-0191",
      "author": "AA Lemke",
      "doi-asserted-by": "publisher",
      "first-page": "321",
      "journal-title": "Pharmacogenomics",
      "key": "2369_CR40",
      "unstructured": "Lemke AA, Hulick PJ, Wake DT et al (2018) Patient perspectives following pharmacogenomics results disclosure in an integrated health system. Pharmacogenomics 19:321–331. https://doi.org/10.2217/pgs-2017-0191",
      "volume": "19",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41436-018-0080-y",
      "author": "KD Levy",
      "doi-asserted-by": "publisher",
      "first-page": "743",
      "journal-title": "Genet Med",
      "key": "2369_CR41",
      "unstructured": "Levy KD, Blake K, Fletcher-Hoppe C et al (2019) Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network. Genet Med 21:743–747. https://doi.org/10.1038/s41436-018-0080-y",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.3402/gha.v6i0.20100",
      "author": "T Loney",
      "doi-asserted-by": "publisher",
      "first-page": "20100",
      "journal-title": "Glob Health Action",
      "key": "2369_CR42",
      "unstructured": "Loney T, Aw T-C, Handysides DG et al (2013) An analysis of the health status of the United Arab Emirates: the “Big 4” public health issues. Glob Health Action 6:20100. https://doi.org/10.3402/gha.v6i0.20100",
      "volume": "6",
      "year": "2013"
    },
    {
      "DOI": "10.1002/cpt.630",
      "author": "JA Luzum",
      "doi-asserted-by": "publisher",
      "first-page": "502",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR43",
      "unstructured": "Luzum JA, Pakyz RE, Elsey AR et al (2017) The pharmacogenomics research network translational pharmacogenetics program: outcomes and metrics of pharmacogenetic implementations across diverse healthcare systems. Clin Pharmacol Ther 102:502–510. https://doi.org/10.1002/cpt.630",
      "volume": "102",
      "year": "2017"
    },
    {
      "DOI": "10.1038/clpt.2010.125",
      "author": "P Madadi",
      "doi-asserted-by": "publisher",
      "first-page": "792",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR44",
      "unstructured": "Madadi P, Joly Y, Avard D et al (2010) Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits. Clin Pharmacol Ther 88:792–795. https://doi.org/10.1038/clpt.2010.125",
      "volume": "88",
      "year": "2010"
    },
    {
      "DOI": "10.1371/journal.pone.0224283",
      "author": "S Madhavan",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS One",
      "key": "2369_CR45",
      "unstructured": "Madhavan S, Bullis E, Myers R et al (2019) Awareness of family health history in a predominantly young adult population. PLoS One 14:e0224283. https://doi.org/10.1371/journal.pone.0224283",
      "volume": "14",
      "year": "2019"
    },
    {
      "DOI": "10.2217/pme.13.92",
      "author": "Y Mai",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "journal-title": "Per Med",
      "key": "2369_CR46",
      "unstructured": "Mai Y, Mitropoulou C, Papadopoulou XE et al (2014) Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece. Per Med 11:15–26. https://doi.org/10.2217/pme.13.92",
      "volume": "11",
      "year": "2014"
    },
    {
      "DOI": "10.2217/pgs-2017-0093",
      "author": "LE Manson",
      "doi-asserted-by": "publisher",
      "first-page": "1041",
      "journal-title": "Pharmacogenomics",
      "key": "2369_CR47",
      "unstructured": "Manson LE, van der Wouden CH, Swen JJ, Guchelaar H-J (2017) The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen. Pharmacogenomics 18:1041–1045. https://doi.org/10.2217/pgs-2017-0093",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s00439-014-1484-7",
      "author": "SD Mooney",
      "doi-asserted-by": "publisher",
      "first-page": "459",
      "journal-title": "Hum Genet",
      "key": "2369_CR48",
      "unstructured": "Mooney SD (2015) Progress towards the integration of pharmacogenomics in practice. Hum Genet 134:459–465. https://doi.org/10.1007/s00439-014-1484-7",
      "volume": "134",
      "year": "2015"
    },
    {
      "DOI": "10.1080/14737167.2017.1385395",
      "author": "AM Moyer",
      "doi-asserted-by": "publisher",
      "first-page": "567",
      "journal-title": "Expert Rev Pharmacoecon Outcomes Res",
      "key": "2369_CR49",
      "unstructured": "Moyer AM, Caraballo PJ (2017) The challenges of implementing pharmacogenomic testing in the clinic. Expert Rev Pharmacoecon Outcomes Res 17:567–577. https://doi.org/10.1080/14737167.2017.1385395",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.1002/mgg3.417",
      "author": "SC Nutter",
      "doi-asserted-by": "publisher",
      "first-page": "307",
      "journal-title": "Mol Genet Genomic Med",
      "key": "2369_CR50",
      "unstructured": "Nutter SC, Gálvez-Peralta M (2018) Pharmacogenomics: from classroom to practice. Mol Genet Genomic Med 6:307–313. https://doi.org/10.1002/mgg3.417",
      "volume": "6",
      "year": "2018"
    },
    {
      "DOI": "10.1038/CLPT.2012.117",
      "author": "PH O’Donnell",
      "doi-asserted-by": "publisher",
      "first-page": "446",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR51",
      "unstructured": "O’Donnell PH, Bush A, Spitz J et al (2012) The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics. Clin Pharmacol Ther 92:446. https://doi.org/10.1038/CLPT.2012.117",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.1002/AJMG.C.31385",
      "author": "PH O’Donnell",
      "doi-asserted-by": "publisher",
      "first-page": "68",
      "journal-title": "Am J Med Genet C Semin Med Genet",
      "key": "2369_CR52",
      "unstructured": "O’Donnell PH, Danahey K, Jacobs M et al (2014) Adoption of a clinical pharmacogenomics implementation program during outpatient care-initial results of the university of Chicago ‘1200 patients project.’ Am J Med Genet C Semin Med Genet 166:68. https://doi.org/10.1002/AJMG.C.31385",
      "volume": "166",
      "year": "2014"
    },
    {
      "DOI": "10.1038/GIM.2016.192",
      "author": "JE Olson",
      "doi-asserted-by": "publisher",
      "first-page": "819",
      "journal-title": "Genet Med",
      "key": "2369_CR53",
      "unstructured": "Olson JE, Vitek CRR, Bell EJ et al (2017) Participant perceived understanding and perspectives toward pharmacogenomics: Mayo Clinic Right Drug, Right Dose, Right Time (RIGHT) Protocol. Genet Med 19:819. https://doi.org/10.1038/GIM.2016.192",
      "volume": "19",
      "year": "2017"
    },
    {
      "author": "LA Orlando",
      "first-page": "287",
      "journal-title": "N C Med J",
      "key": "2369_CR54",
      "unstructured": "Orlando LA, Buchanan AH, Hahn SE et al (2013) Development and validation of a primary care-based family health history and decision support program (MeTree). N C Med J 74:287–296",
      "volume": "74",
      "year": "2013"
    },
    {
      "DOI": "10.1002/mgg3.636",
      "author": "LA Orlando",
      "doi-asserted-by": "publisher",
      "journal-title": "Mol Genet Genomic Med",
      "key": "2369_CR55",
      "unstructured": "Orlando LA, Voils C, Horowitz CR et al (2019) IGNITE network: response of patients to genomic medicine interventions. Mol Genet Genomic Med 7:e636. https://doi.org/10.1002/mgg3.636",
      "volume": "7",
      "year": "2019"
    },
    {
      "DOI": "10.3390/JPM4010035",
      "author": "CL Overby",
      "doi-asserted-by": "publisher",
      "first-page": "35",
      "journal-title": "J Pers Med",
      "key": "2369_CR56",
      "unstructured": "Overby CL, Erwin AL, Abul-Husn NS et al (2014) Physician attitudes toward adopting genome-guided prescribing through clinical decision support. J Pers Med 4:35. https://doi.org/10.3390/JPM4010035",
      "volume": "4",
      "year": "2014"
    },
    {
      "DOI": "10.3390/jpm8030024",
      "author": "A Owusu Obeng",
      "doi-asserted-by": "publisher",
      "first-page": "24",
      "journal-title": "J Pers Med",
      "key": "2369_CR57",
      "unstructured": "Owusu Obeng A, Fei K, Levy K et al (2018) Physician-reported benefits and barriers to clinical implementation of genomic medicine: a multi-site IGNITE-network survey. J Pers Med 8:24. https://doi.org/10.3390/jpm8030024",
      "volume": "8",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s12888-017-1412-1",
      "author": "V Pérez",
      "doi-asserted-by": "publisher",
      "first-page": "250",
      "journal-title": "BMC Psychiatry",
      "key": "2369_CR58",
      "unstructured": "Pérez V, Salavert A, Espadaler J et al (2017) Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial. BMC Psychiatry 17:250. https://doi.org/10.1186/s12888-017-1412-1",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.2217/pgs-2017-0042",
      "author": "RC Pierson",
      "doi-asserted-by": "publisher",
      "first-page": "835",
      "journal-title": "Pharmacogenomics",
      "key": "2369_CR59",
      "unstructured": "Pierson RC, Gufford BT, Desta Z, Eadon MT (2017) Clinical and educational impact of pharmacogenomics testing: a case series from the INGENIOUS trial. Pharmacogenomics 18:835–841. https://doi.org/10.2217/pgs-2017-0042",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1038/CLPT.2011.371",
      "author": "JM Pulley",
      "doi-asserted-by": "publisher",
      "first-page": "87",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR60",
      "unstructured": "Pulley JM, Denny JC, Peterson JF et al (2012) Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. Clin Pharmacol Ther 92:87. https://doi.org/10.1038/CLPT.2011.371",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.2217/pme-2019-0110",
      "author": "F Radouani",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "journal-title": "Per Med",
      "key": "2369_CR61",
      "unstructured": "Radouani F, Zass L, Hamdi Y et al (2020) A review of clinical pharmacogenetics Studies in African populations. Per Med 17:155–170. https://doi.org/10.2217/pme-2019-0110",
      "volume": "17",
      "year": "2020"
    },
    {
      "DOI": "10.1038/clpt.2014.137",
      "author": "LJ Rasmussen-Torvik",
      "doi-asserted-by": "publisher",
      "first-page": "482",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR62",
      "unstructured": "Rasmussen-Torvik LJ, Stallings SC, Gordon AS et al (2014) Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems. Clin Pharmacol Ther 96:482–489. https://doi.org/10.1038/clpt.2014.137",
      "volume": "96",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.jmoldx.2017.04.002",
      "author": "LJ Rasmussen-Torvik",
      "doi-asserted-by": "publisher",
      "first-page": "561",
      "journal-title": "J Mol Diagn",
      "key": "2369_CR63",
      "unstructured": "Rasmussen-Torvik LJ, Almoguera B, Doheny KF et al (2017) Concordance between research sequencing and clinical pharmacogenetic genotyping in the eMERGE-PGx study. J Mol Diagn 19:561–566. https://doi.org/10.1016/j.jmoldx.2017.04.002",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nature15817",
      "author": "MV Relling",
      "doi-asserted-by": "publisher",
      "first-page": "343",
      "journal-title": "Nature",
      "key": "2369_CR64",
      "unstructured": "Relling MV, Evans WE (2015) Pharmacogenomics in the clinic. Nature 526:343–350. https://doi.org/10.1038/nature15817",
      "volume": "526",
      "year": "2015"
    },
    {
      "DOI": "10.1038/clpt.2010.279",
      "author": "MV Relling",
      "doi-asserted-by": "publisher",
      "first-page": "464",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR65",
      "unstructured": "Relling MV, Klein TE (2011) CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network. Clin Pharmacol Ther 89:464–467. https://doi.org/10.1038/clpt.2010.279",
      "volume": "89",
      "year": "2011"
    },
    {
      "DOI": "10.1038/s41439-021-00135-z",
      "author": "C Runcharoen",
      "doi-asserted-by": "publisher",
      "journal-title": "Hum Genome Var",
      "key": "2369_CR66",
      "unstructured": "Runcharoen C, Fukunaga K, Sensorn I et al (2021) Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network (SEAPharm). Hum Genome Var. https://doi.org/10.1038/s41439-021-00135-z",
      "year": "2021"
    },
    {
      "DOI": "10.3122/jabfm.2017.06.170145",
      "author": "EJ Schwartz",
      "doi-asserted-by": "publisher",
      "first-page": "701",
      "journal-title": "J Am Board Fam Med",
      "key": "2369_CR67",
      "unstructured": "Schwartz EJ, Turgeon J, Patel J et al (2017) Implementation of a standardized medication therapy management plus approach within primary care. J Am Board Fam Med 30:701–714. https://doi.org/10.3122/jabfm.2017.06.170145",
      "volume": "30",
      "year": "2017"
    },
    {
      "DOI": "10.2217/pgs-2017-0137",
      "author": "SA Scott",
      "doi-asserted-by": "publisher",
      "first-page": "1381",
      "journal-title": "Pharmacogenomics",
      "key": "2369_CR68",
      "unstructured": "Scott SA, Obeng AO, Botton MR et al (2017) Institutional Profile Institutional profile: translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai. Pharmacogenomics 18:1381–1386. https://doi.org/10.2217/pgs-2017-0137",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1038/CLPT.2013.59",
      "author": "A Shuldiner",
      "doi-asserted-by": "publisher",
      "first-page": "207",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR69",
      "unstructured": "Shuldiner A, Relling M, Peterson J et al (2013) The pharmacogenomics research network translational pharmacogenetics program: overcoming challenges of real-world implementation. Clin Pharmacol Ther 94:207. https://doi.org/10.1038/CLPT.2013.59",
      "volume": "94",
      "year": "2013"
    },
    {
      "DOI": "10.3389/fphar.2020.00527",
      "author": "C Sung",
      "doi-asserted-by": "publisher",
      "first-page": "527",
      "journal-title": "Front Pharmacol",
      "key": "2369_CR70",
      "unstructured": "Sung C, Tan L, Limenta M et al (2020) Usage pattern of carbamazepine and associated severe cutaneous adverse reactions in Singapore following implementation of HLA-B*15:02 genotyping as standard-of-care. Front Pharmacol 11:527. https://doi.org/10.3389/fphar.2020.00527",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1371/journal.pmed.0040209",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS Med",
      "key": "2369_CR71",
      "unstructured": "Swen JJ, Huizinga TW, Gelderblom H et al (2007) Translating pharmacogenomics: challenges on the road to the clinic. PLoS Med 4:e209. https://doi.org/10.1371/journal.pmed.0040209",
      "volume": "4",
      "year": "2007"
    },
    {
      "DOI": "10.3390/pharmaceutics12090809",
      "author": "EB Tata",
      "doi-asserted-by": "publisher",
      "journal-title": "Pharmaceutics",
      "key": "2369_CR72",
      "unstructured": "Tata EB, Ambele MA, Pepper MS (2020) Barriers to implementing clinical pharmacogenetics testing in Sub-Saharan Africa: a critical review. Pharmaceutics. https://doi.org/10.3390/pharmaceutics12090809",
      "year": "2020"
    },
    {
      "DOI": "10.2217/pgs.14.31",
      "author": "K Teng",
      "doi-asserted-by": "publisher",
      "first-page": "587",
      "journal-title": "Pharmacogenomics",
      "key": "2369_CR73",
      "unstructured": "Teng K, DiPiero J, Meese T et al (2014) Cleveland Clinic’s Center for personalized healthcare: setting the stage for value-based care. Pharmacogenomics 15:587–591. https://doi.org/10.2217/pgs.14.31",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1002/cpt.1567",
      "author": "TM Truong",
      "doi-asserted-by": "publisher",
      "first-page": "1179",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR74",
      "unstructured": "Truong TM, Apfelbaum J, Shahul S et al (2019) The ImPreSS trial: implementation of point-of-care pharmacogenomic decision support in perioperative care. Clin Pharmacol Ther 106:1179–1183. https://doi.org/10.1002/cpt.1567",
      "volume": "106",
      "year": "2019"
    },
    {
      "DOI": "10.1053/j.ajkd.2019.06.006",
      "author": "EM Umeukeje",
      "doi-asserted-by": "publisher",
      "first-page": "811",
      "journal-title": "Am J Kidney Dis",
      "key": "2369_CR75",
      "unstructured": "Umeukeje EM, Young BA (2019) Genetics and ESKD disparities in African Americans. Am J Kidney Dis 74:811–821. https://doi.org/10.1053/j.ajkd.2019.06.006",
      "volume": "74",
      "year": "2019"
    },
    {
      "DOI": "10.1002/cpt.602",
      "author": "C van der Wouden",
      "doi-asserted-by": "publisher",
      "first-page": "341",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR76",
      "unstructured": "van der Wouden C, Cambon-Thomsen A, Cecchin E et al (2017) Implementing pharmacogenomics in Europe: design and implementation strategy of the ubiquitous pharmacogenomics consortium. Clin Pharmacol Ther 101:341–358. https://doi.org/10.1002/cpt.602",
      "volume": "101",
      "year": "2017"
    },
    {
      "DOI": "10.1038/CLPT.2013.229",
      "author": "SL Van Driest",
      "doi-asserted-by": "publisher",
      "first-page": "423",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR77",
      "unstructured": "Van Driest SL, Shi Y, Bowton EA et al (2014) Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing. Clin Pharmacol Ther 95:423. https://doi.org/10.1038/CLPT.2013.229",
      "volume": "95",
      "year": "2014"
    },
    {
      "DOI": "10.1186/s12920-015-0162-5",
      "author": "KW Weitzel",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "BMC Med Genomics",
      "key": "2369_CR78",
      "unstructured": "Weitzel KW, Alexander M, Bernhardt BA et al (2016) The IGNITE network: a model for genomic medicine implementation and research. BMC Med Genomics 9:1. https://doi.org/10.1186/s12920-015-0162-5",
      "volume": "9",
      "year": "2016"
    },
    {
      "DOI": "10.1038/clpt.2012.96",
      "author": "M Whirl-Carrillo",
      "doi-asserted-by": "publisher",
      "first-page": "414",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2369_CR79",
      "unstructured": "Whirl-Carrillo M, McDonagh EM, Hebert JM et al (2012) Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther 92:414–417. https://doi.org/10.1038/clpt.2012.96",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.1185/03007995.2015.1063483",
      "author": "JG Winner",
      "doi-asserted-by": "publisher",
      "first-page": "1633",
      "journal-title": "Curr Med Res Opin",
      "key": "2369_CR80",
      "unstructured": "Winner JG, Carhart JM, Altar CA et al (2015) Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation. Curr Med Res Opin 31:1633–1643. https://doi.org/10.1185/03007995.2015.1063483",
      "volume": "31",
      "year": "2015"
    },
    {
      "DOI": "10.18553/jmcp.2002.8.4.278",
      "author": "W Zachary III",
      "doi-asserted-by": "publisher",
      "first-page": "278",
      "journal-title": "J Manag Care Pharm",
      "key": "2369_CR81",
      "unstructured": "Zachary W III, Armstrong EP (2002) Health care professionals’ perceptions of the role of pharmacogenomic data. J Manag Care Pharm 8:278–284. https://doi.org/10.18553/jmcp.2002.8.4.278",
      "volume": "8",
      "year": "2002"
    },
    {
      "DOI": "10.3389/fphar.2020.01217",
      "author": "NK Zgheib",
      "doi-asserted-by": "publisher",
      "first-page": "1217",
      "journal-title": "Front Pharmacol",
      "key": "2369_CR82",
      "unstructured": "Zgheib NK, Patrinos GP (2020) Editorial: pharmacogenetics research and clinical applications: an international landscape of the accomplishments, challenges, and opportunities. Front Pharmacol 11:1217. https://doi.org/10.3389/fphar.2020.01217",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1542/peds.2013-1416",
      "author": "SC Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "e1258",
      "journal-title": "Pediatrics",
      "key": "2369_CR83",
      "unstructured": "Zhang SC, Bruce C, Hayden M, Rieder MJ (2014) Public perceptions of pharmacogenetics. Pediatrics 133:e1258–e1267. https://doi.org/10.1542/peds.2013-1416",
      "volume": "133",
      "year": "2014"
    }
  ],
  "reference-count": 83,
  "references-count": 83,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s00439-021-02369-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Clinical implementation of drug metabolizing gene-based therapeutic interventions worldwide"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "141"
}